Description
“A Superior Cartilage Nutrient for Joint Comfort” features Jerry Hickey (RPh) explaining how UC-II®, a form of undenatured type II collagen, supports long-term joint health. He reviews research showing its effects in both rheumatoid and osteoarthritis, including improved mobility, reduced stiffness, and lower pain scores. Hickey also highlights how UC-II® compares to standard joint supplements and NSAIDs, and why its immune-modulating role may help protect cartilage over time—making it a useful option beyond just short-term relief.
A Superior Cartilage Nutrient for Joint Comfort
Guest
This time, there are no guests—just Jerry Hickey delving deeply into today's topic.
Category
Joint Health, Supplements
Tags
This episode currently does not include podcast tags related to its content. We are in the process of updating and adding relevant tags to improve accessibility and categorization.
About The Host
Jerry Hickey is a pharmacist and clinical nutritionist who hosts the Invite Health Podcast. He breaks down the latest findings on vitamins, minerals, and herbal therapies to help listeners navigate natural solutions for long-term wellness. His podcast provides digestible advice on how to optimize energy, immunity, and organ health through strategic supplementation.
Jerry Hickey is a pharmacist and clinical nutritionist who hosts the Invite Health Podcast. He breaks down the latest findings on vitamins, minerals, and herbal therapies to help listeners navigate natural solutions for long-term wellness. His podcast provides digestible advice on how to optimize energy, immunity, and organ health through strategic supplementation.
About The Guest
This episode features Jerry Hickey as the sole presenter, offering his expertise and insights.
This episode features Jerry Hickey as the sole presenter, offering his expertise and insights.
Support the Guest
This episode does not include any guest appearances, or information about the guests' website, Instagram, Facebook, or Twitter profiles is currently unknown to us. We’ll update this page as soon as more details become available.